Connor, Clark & Lunn Investment Management (CC&L)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Sell |
|
|||||
|
2025
Q1 | $8.93M | Buy |
|
|||||
|
2024
Q4 | $7.01M | Sell |
|
|||||
|
2024
Q3 | $23.1M | Buy |
|
|||||
|
2024
Q2 | $4.18M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $24.9M | Sell |
|
|||||
|
2022
Q2 | $49.3M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $33M | Buy |
|
|||||
|
2020
Q1 | $23.4M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $947K | Sell |
|
|||||
|
2018
Q1 | $13.8M | Sell |
|
|||||
|
2017
Q4 | $28.8M | Sell |
|
|||||
|
2017
Q3 | $44.5M | Buy |
|
|||||
|
2017
Q2 | $37.8M | Buy |
|
|||||
|
2017
Q1 | $27.1M | Buy |
|
|||||
|
2016
Q4 | $1.06M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.15M | Hold |
|
|||||
|
2014
Q1 | $1.19M | Sell |
|
|||||
|
2013
Q4 | $4.83M | Sell |
|
|||||
|
2013
Q3 | $4.57M | Buy |
|